Director/PDMR Shareholding

RNS Number : 5181H
Deltex Medical Group PLC
16 March 2015
 

Deltex Medical Group plc
("Deltex Medical" or "the Company")

Director/PDMR Shareholding

 

16 March 2015 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that on 13 March 2015 three Directors purchased shares in the Company.

 

Tim Irish, non-executive Director, notified the Company on 13 March 2015 of the purchase of 500,000 Ordinary Shares at a price of 5.00 pence per Ordinary Share. As a result Mr Irish's shareholding totals 1,848,484 ordinary shares (representing 0.87 per cent. of the issued share capital of Deltex Medical).

 

Sir Duncan Nichol, non-executive Director, notified the Company on 14 March 2015 of the purchase of 180,000 Ordinary Shares at a price of 5.40 pence per Ordinary Share. As a result Sir Duncan's shareholding totals 1,166,912 ordinary shares (representing 0.55 per cent. of the issued share capital of Deltex Medical).

 

Paul Mitchell, Finance Director notified the Company on 15 March 2015 of the purchase of 156,981 Ordinary Shares at an average price of 5.41 pence per Ordinary Share. As a result Mr Mitchell's shareholding totals 509,812 ordinary shares (representing 0.24 per cent. of the issued share capital of Deltex Medical).

 

For further information, please contact:-

 

Deltex Medical Group plc                                   

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman                


Ewan Phillips, Chief Executive               


Paul Mitchell, Finance Director               


Barry Curtis, Company Secretary




Nominated Adviser & Broker


Arden Partners plc

020 7614 5900

Chris Hardie                                                     


 

Joint Broker

Zeus Capital Limited

Dominic Wilson

John Goold

 

 

 

020 7533 7727

 

Financial Public Relations


Newgate

020 7653 9850

Tim Thompson


Robyn McConnachie

Ed Treadwell


 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIIVEIRLIE
UK 100

Latest directors dealings